448 POSTER NKTR-105, a novel PEGylated-docetaxel, demonstrates superior anti-tumor activity compared to docetaxel in human non-small cell lung and colon ca... NKTR-105, a novel multi-arm PEGylated docetaxel conjugate, isentering phase 1 development in patients with refractory solidmalignancies. In...